Q&A: Omid Farokhzad on Nanomedicine in Cancer.
Omid Farokhzad, MD, director of the Center for Nanomedicine at Brigham and Women's Hospital in Boston, MA, discusses the challenges of moving nanotherapies from the realm of academic innovation to the clinic, stressing the importance of thoroughly understanding the nano-bio interface and its complexities for successful translation.
D017277:Drug Approval; D016503:Drug Delivery Systems; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis / Q000628:therapy*; D000068936:Theranostic Nanomedicine / Q000379:methods*